Edwards Lifesciences Q2 Sales Surge Nearly 12%
Edwards Lifesciences posted strong Q2 results with sales rising 11.9% to $1.53 billion, beating Wall Street expectations. While net earnings dipped 7.7%, adjusted EPS hit
Edwards Lifesciences posted strong Q2 results with sales rising 11.9% to $1.53 billion, beating Wall Street expectations. While net earnings dipped 7.7%, adjusted EPS hit
Dexcom has introduced Smart Food Logging, an AI-powered feature now available on its G7 and Stelo continuous glucose monitoring (CGM) systems. The new tool allows
Cognito Therapeutics has reported new clinical data reinforcing the effectiveness of its non-invasive Spectris neuromodulation system in treating Alzheimer’s disease. Presented at the Alzheimer’s Association
Carlsmed has completed its first cervical spine procedure using the AI-powered Aprevo system. The personalized implant was used by Dr. Joseph Osorio at UC San
AngioDynamics has enrolled the first patient in its AMBITION BTK study, evaluating the Auryon atherectomy system for treating below-the-knee critical limb ischemia. The trial pairs
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
